Drug & Medication Database

11 DESCRIPTION Insulin aspart is a rapid-acting insulin analog for subcutaneous or intravenous administration. Insulin aspart is homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae . Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 daltons.

Brands: Fiasp

Manufactured by NOVO NORDISK INC. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: INSULIN ASPART PROTAMINE RECOMBINANT (50 UNITS/ML); INSULIN ASPART RECOMBINANT (50 UNITS/ML). Application: BLA021810.

Manufactured by NOVO NORDISK INC. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: INSULIN ASPART PROTAMINE RECOMBINANT (50 UNITS/ML); INSULIN ASPART RECOMBINANT (50 UNITS/ML). Application: BLA021810.

11 DESCRIPTION Insulin aspart-szjj is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Escherichia coli . Insulin aspart-szjj has a molecular weight of 5825.8 Da. MERILOG (insulin aspart-szjj) injection is a sterile, clear, and colorless solution for subcutaneous use.

Brands: Merilog

11 DESCRIPTION Insulin aspart-xjhz is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28 and is produced by recombinant DNA technology utilizing Pichia pastoris . Insulin aspart-xjhz has the empirical formula C 256 H 381 N 65 O 79 S 6 and a molecular weight of 5825.8 Da. Figure 1. Structural formula of insulin aspart-xjhz.

Brands: Insulin Diluting Medium For Kirsty, Kirsty

11 DESCRIPTION Insulin degludec is a long-acting basal human insulin analog for subcutaneous injection produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification. Insulin degludec differs from human insulin in that the amino acid threonine in position B30 has been omitted and a side-chain consisting of glutamic acid and a C16 fatty acid has been attached (chemical name: LysB29(Nε-hexadecandioyl-γ-Glu) des(B30) human insulin).

Brands: Insulin Degludec

11 DESCRIPTION Insulin degludec Insulin degludec is a long-acting basal human insulin analog. Insulin degludec is produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification.

Brands: Xultophy 100/3.6

11 DESCRIPTION Insulin detemir is a long-acting recombinant human insulin analog produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification. Insulin detemir differs from human insulin in that the amino acid threonine in position B30 has been omitted, and a C14 fatty acid chain has been attached to the amino acid B29. Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa.

Brands: Levemir

Dosage form: LIQUID. Active ingredients: INSULIN EFSITORA ALFA (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Insulin glargine is a long-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli (K12) as the production organism. Insulin glargine differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine and two arginines are added to the C-terminus of the B-chain.

Brands: Basaglar Kwikpen, Basaglar Tempo Pen

Dosage form: POWDER. Active ingredients: INSULIN GLARGINE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION SOLIQUA 100/33 is a combination of insulin glargine, an insulin analog, and lixisenatide, a GLP-1 receptor agonist. Insulin glargine is a human insulin analog produced by recombinant DNA technology utilizing a nonpathogenic laboratory strain of Escherichia coli (K12) as the production organism. The minimum potency of insulin glargine is NLT 15 units/mg.

Brands: Soliqua 100/33

11 DESCRIPTION Insulin glargine-aglr is a long-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli (K12). Insulin glargine-aglr differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine and two arginines are added to the C-terminus of the B-chain. Insulin glargine-aglr has a molecular weight of 6063 Da.

Brands: Rezvoglar Kwikpen

11 DESCRIPTION Insulin glargine-yfgn is a long-acting human insulin analog produced by recombinant DNA technology utilizing a recombinant yeast strain, Pichia pastoris . Insulin glargine-yfgn differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine and two arginines are added to the C-terminus of the B-chain. Insulin glargine-yfgn has a molecular weight of 6063 Da.

Brands: Insulin Glargine

11 DESCRIPTION Insulin glulisine is a rapid-acting human insulin analog used to lower blood glucose. Insulin glulisine is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli (K12). Insulin glulisine differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. Insulin glulisine has a molecular weight of 5.823 kDa.

Brands: Apidra, Apidra Solostar

11 DESCRIPTION 11.1 AFREZZA Cartridges Human insulin is a rapid acting human insulin produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli (K12). Chemically, human insulin has the empirical formula C 257 H 383 N 65 O 77 S 6 and a molecular weight of 5808.

Brands: Afrezza

11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro differs from human insulin in that the amino acid proline at position B28 is replaced by lysine and the lysine in position B29 is replaced by proline. Insulin lispro has a molecular weight of 5808 Da, identical to that of human insulin.

Brands: Admelog

11 DESCRIPTION Insulin lispro-aabc is a rapid-acting human insulin analog used to lower blood glucose. Insulin lispro-aabc is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro-aabc differs from human insulin in that the amino acid proline at position B28 is replaced by lysine and the lysine in position B29 is replaced by proline.

Brands: Lyumjev, Lyumjev Kwikpen, Lyumjev Tempo Pen +1 more

Dosage form: CRYSTAL. Active ingredients: INSULIN HUMAN (1 g/g). Category: BULK INGREDIENT.

Purpose Reduces insulin resistance, restores defective insulin receptors, and maintains a normal blood sugar level*

Brands: Insulizen

PURPOSE Neuroendocrine Support

Brands: Guna-igf

Used to remove acne, moisturize and repair skin.

Brands: Intenseclarifyingcleanserrepairtoner

Antihypersensitivity Anticavity

Brands: Intensive Enamel Repair Whitening Tp

Purpose Hypericum perforatum 3X HPUS.......Topical Analgesic

Brands: Frankincense And Myrrh

Purpose Anti-itch

Brands: Zourunan Intensive Healing Lotion. For Eczema

Manufactured by SCHERING. Dosage form: VIAL. Active ingredients: INTERFERON ALFA-2B (18MIU/VIAL). Application: BLA103132.

Manufactured by INTERFERON SCIENCES. Dosage form: VIAL. Active ingredients: INTERFERON ALFA-N3 (5MIU/VIAL). Application: BLA103158.

11 DESCRIPTION Interferon beta-1a, an interferon beta, is a 166 amino acid glycoprotein with a molecular weight of approximately 22,500 daltons. It is produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of AVONEX is identical to that of natural human interferon beta.

Brands: Avonex, Avonex Pen, Avonex

11 DESCRIPTION Interferon beta-1b is a purified, sterile, lyophilized protein product produced by recombinant DNA techniques. Interferon beta-1b is manufactured by bacterial fermentation of a strain of Escherichia coli that bears a genetically engineered plasmid containing the gene for human interferon betaser17. The native gene was obtained from human fibroblasts and altered in a way that substitutes serine for the cysteine residue found at position 17.

Brands: Betaseron

11 DESCRIPTION ACTIMMUNE (Interferon gamma-1b), an interferon gamma, is a single-chain polypeptide containing 140 amino acids. Production of ACTIMMUNE is achieved by fermentation of a genetically engineered Escherichia coli bacterium containing the DNA which encodes for the recombinant protein. Purification of the product is achieved by conventional column chromatography.

Brands: Actimmune